C

Communal Non-Profit Enterprise Regional Center of Oncology | Kharkiv, Ukraine

Research site
(Unclaimed)
Location
4, Lisoparkivska, str., Kharkiv, Kharkiv, Ukraine

Site insights

Top conditions

Top treatments

Veliparib
Paclitaxel
Carboplatin
TAK-788
Platinum
docetaxel
Eculizumab
Ruxolitinib
Pomalidomide
Tafasitamab

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

7 of 18 total trials

A Phase 3 Study to Assess Efficacy and Safety of Tafasitamab Plus Lenalidomide and Rituximab Compared to Placebo Plus Lenalidomide and Rituximab in Patients With Relapsed/Refractory (R/R) Follicular Lymphoma or Marginal Zone Lymphoma. (InMIND)

This is a Phase 3 double-blind, placebo-controlled, randomized study designed to investigate whether tafasitamab and lenalidomide as an add-on to rit...

Active, not recruiting
Marginal Zone Lymphoma
Follicular Lymphoma
Drug: rituximab
Drug: placebo

A study designed tocompare progression-free survival (PFS) in participants with t(11;14)-positive MM treated with venetoclax in combination with dexa...

Active, not recruiting
Multiple Myeloma
Drug: Dexamethasone
Drug: Pomalidomide

This study is being done to find out if zanidatamab, when given with chemotherapy plus or minus tislelizumab, is safe and works better than trastuzum...

Enrolling
Gastroesophageal Adenocarcinoma
Gastric Neoplasms
Drug: Tislelizumab
Drug: Capecitabine

The purpose of this research study is to determine the safety and tolerability of TL-895. There are 2 parts of this study. Part 1 tested increasing d...

Active, not recruiting
Relapsed/Refractory B Cell Malignancies
Treatment-Naive B Cell Malignancies
Drug: TL-895
Drug: Navtemadlin

The purpose of this study is to assess the efficacy and safety of platinum-based chemotherapy with or without INCMGA00012 in participants with metast...

Active, not recruiting
Metastatic Nonsquamous Non-Small Cell Lung Cancer
Metastatic Squamous Non-Small Cell Lung Cancer
Drug: nab-Paclitaxel
Drug: Paclitaxel

Myelofibrosis is a type of bone marrow cancer that usually develops slowly and disrupts body's normal production of blood cells. It causes bone marro...

Active, not recruiting
Myelofibrosis (MF)
Drug: Ruxolitinib
Drug: Navitoclax

The purpose of this study is to compare the effectiveness of TAK-788 as first-line treatment with that of platinum-based chemotherapy in participants...

Active, not recruiting
Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
Drug: Cisplatin
Drug: Pemetrexed

Trial sponsors

AbbVie logo
Incyte logo
Agenus logo
Debiopharm logo
Hengrui Medicine logo
H
Ipsen logo
Jazz Pharmaceuticals logo
J
Merck KGaA (EMD Serono) logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems